107 related articles for article (PubMed ID: 32633373)
1. Identification of PTK7 as a promising therapeutic target for thyroid cancer.
Duan F; Tang J; Kong FL; Zou HW; Ni BL; Yu JC
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6809-6817. PubMed ID: 32633373
[TBL] [Abstract][Full Text] [Related]
2. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
Liu K; Song G; Zhang X; Li Q; Zhao Y; Zhou Y; Xiong R; Hu X; Tang Z; Feng G
World J Surg Oncol; 2017 May; 15(1):105. PubMed ID: 28545451
[TBL] [Abstract][Full Text] [Related]
3. The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer.
Sun JJ; Li HL; Guo SJ; Ma H; Liu SJ; Liu D; Xue FX
Dis Markers; 2019; 2019():5380197. PubMed ID: 30944666
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
5. Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway.
Meng L; Sefah K; O'Donoghue MB; Zhu G; Shangguan D; Noorali A; Chen Y; Zhou L; Tan W
PLoS One; 2010 Nov; 5(11):e14018. PubMed ID: 21103379
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer.
Zhang H; Wang A; Qi S; Cheng S; Yao B; Xu Y
Int J Mol Sci; 2014 Jul; 15(7):11665-77. PubMed ID: 24987951
[TBL] [Abstract][Full Text] [Related]
7. PTK7 regulates Id1 expression in CD44-high glioma cells.
Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
[TBL] [Abstract][Full Text] [Related]
8. KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.
Han Y; Chen J; Wei D; Wang B
Comput Math Methods Med; 2022; 2022():6426800. PubMed ID: 36017147
[TBL] [Abstract][Full Text] [Related]
9. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Prebet T; Lhoumeau AC; Arnoulet C; Aulas A; Marchetto S; Audebert S; Puppo F; Chabannon C; Sainty D; Santoni MJ; Sebbagh M; Summerour V; Huon Y; Shin WS; Lee ST; Esterni B; Vey N; Borg JP
Blood; 2010 Sep; 116(13):2315-23. PubMed ID: 20558616
[TBL] [Abstract][Full Text] [Related]
10. A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy.
Xu T; Wang C; Wang X; Wang E; Wang B; Sun M
Med Oncol; 2023 Jul; 40(8):226. PubMed ID: 37405498
[TBL] [Abstract][Full Text] [Related]
11. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
[TBL] [Abstract][Full Text] [Related]
12. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
13. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
14. PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.
Jiang W; He J; Lv B; Xi X; He G; He J
Histol Histopathol; 2020 May; 35(5):489-495. PubMed ID: 31701509
[TBL] [Abstract][Full Text] [Related]
15. ENST00000489707.5 Is a Preferred Alternative Splicing Variant of PTK7 in Adrenocortical Cancer and Shows Potential Prognostic Value.
Bie J; Liu K; Song G; Hu X; Xiong R; Zhang X; Shi X; Wang Z
Med Sci Monit; 2019 Nov; 25():8326-8334. PubMed ID: 31689287
[TBL] [Abstract][Full Text] [Related]
16. Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.
Shin WS; Lee HW; Lee ST
FASEB J; 2019 Nov; 33(11):12960-12971. PubMed ID: 31490704
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.
Chen R; Khatri P; Mazur PK; Polin M; Zheng Y; Vaka D; Hoang CD; Shrager J; Xu Y; Vicent S; Butte AJ; Sweet-Cordero EA
Cancer Res; 2014 May; 74(10):2892-902. PubMed ID: 24654231
[TBL] [Abstract][Full Text] [Related]
18. Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells.
Katoh M; Katoh M
Int J Mol Med; 2007 Sep; 20(3):405-9. PubMed ID: 17671748
[TBL] [Abstract][Full Text] [Related]
19. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis.
Shin WS; Maeng YS; Jung JW; Min JK; Kwon YG; Lee ST
Biochem Biophys Res Commun; 2008 Jul; 371(4):793-8. PubMed ID: 18471990
[TBL] [Abstract][Full Text] [Related]
20. Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis.
Shin WS; Na HW; Lee ST
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2251-60. PubMed ID: 25986862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
